A referral for Cell Based Immune Therapy in Japan is only available for Survivorship Platinum Plus Action Plan participants. Grace will navigate before, during and after your visit to Japan. The therapy has been available since the early 1990s, with tens of thousands of patients treated.
The Grace Gawler Institute has referred patients to our Japanese colleague since 2015. He is a pioneer and world expert in cancer immunology. Visit Survivor Stories Page.
This type of therapy has been proven to be effective for most types of cancers. It is also effective against cancer recurrence and promotes prevention. It has been shown to shrink and slow growth of tumours. In some cases tumours were observed to disappear after treatment. It can be a value-add to conventional treatment or can be used to support and restore your immune system.
Benefits of cell based immune therapies:
In addition to cancer prevention, cancer recurrence and even palliative treatment, immune cell therapy is used value add treatment in patients who receive standard regimens of radiotherapy and chemotherapy to strengthen their immune system. Furthermore, immune cell therapy is expected to improve outcomes and reduce side effects for patients undergoing standard cancer treatments.
About cell based immune therapy:
The human body is naturally equipped with a protective defence capacity comprising of immune cells, capable of controlling cancer. Cell based immune therapy is a treatment modality for boosting the human body’s defence capacity.
In the beginning of the process, blood samples are taken from a patient for culture. The immune cells are harvested, activated and multiplied in the laboratory. The activated cells are then injected in a series of vaccines over 10-14 days.
A value-add to conventional treatments:
In addition to cancer prevention, cancer recurrence and even palliative treatment, immune cell therapy is used value add treatment in patients who receive standard regimens of radiotherapy and chemotherapy to strengthen their immune system.
Furthermore, immune cell therapy is expected to improve outcomes and reduce side effects for patients undergoing standard cancer treatments.